OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current concepts and novel targets for antiplatelet therapy
Meinrad Gawaz, Tobias Geisler, Oliver Borst
Nature Reviews Cardiology (2023) Vol. 20, Iss. 9, pp. 583-599
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Low-dose aspirin for the prevention of atherosclerotic cardiovascular disease
Carlo Patrono
European Heart Journal (2024) Vol. 45, Iss. 27, pp. 2362-2376
Open Access | Times Cited: 13

Platelets as an inter‐player between hyperlipidaemia and atherosclerosis
Nailin Li
Journal of Internal Medicine (2024) Vol. 296, Iss. 1, pp. 39-52
Open Access | Times Cited: 10

Polydatin mitigates thrombosis by inhibiting PHD2-induced proline hydroxylation on collagen, reducing platelet adhesion
Kaixin Liu, Chuanjing Cheng, Jin Yan, et al.
Phytomedicine (2025) Vol. 138, pp. 156392-156392
Closed Access

Evidence and Mechanisms of Resveratrol Against Platelet Function: A Literature Review and Network Pharmacology
Ruijie Wang, Yi-Ting Chen, Xinyu Zhao, et al.
Food Reviews International (2025), pp. 1-14
Closed Access

A novel antibody against GPIbα inhibits platelet function and thrombosis without increasing bleeding
Lili Zhao, Jiahao Du, Yuxin Jin, et al.
International Journal of Biological Macromolecules (2025), pp. 140739-140739
Closed Access

Association between pan-immune-inflammation value and coronary heart disease in elderly population: a cross-sectional study
Ruicong Ma, Jinyi Ren, Xianmei Chen, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access

Click chemistry-functionalized gold nanoparticles for the functional reversal of P2Y12 inhibitors
Yang An, Jihua Liu, Xiaoyu Cheng, et al.
Matter (2025) Vol. 8, Iss. 3, pp. 101997-101997
Closed Access

Neutrophils: Linking Inflammation to Thrombosis and Unlocking New Treatment Horizons
Haokun Li, Wei Shan, Xi Zhao, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1965-1965
Open Access

NR4A1 Acts as a Novel Regulator of Platelet Activation and Thrombus Formation
Wenhua Liu, Gaoxiang Li, Jianfeng Shi, et al.
Circulation Research (2025)
Closed Access

Large-scale lipidomics profiling reveals characteristic lipid signatures associated with an increased cardiovascular risk
Tobias Harm, Kristina Dittrich, Adrian Brun, et al.
Clinical Research in Cardiology (2023) Vol. 112, Iss. 11, pp. 1664-1678
Open Access | Times Cited: 14

Antiplatelet strategies: past, present, and future
Livia Stanger, Adriana Yamaguchi, Michael Holinstat
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 12, pp. 3317-3328
Open Access | Times Cited: 10

Noninvasive platelet membrane‐coated Fe3O4 nanoparticles identify vulnerable atherosclerotic plaques
Yuyu Li, Yujie Wang, Zequn Xia, et al.
Smart Medicine (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 3

Novel Small-Molecule Atypical Chemokine Receptor 3 Agonists: Design, Synthesis, and Pharmacological Evaluation for Antiplatelet Therapy
Alp Bayrak, Martyna Szpakowska, Valerie Dicenta, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 14553-14573
Closed Access | Times Cited: 3

Machine learning insights into thrombo-ischemic risks and bleeding events through platelet lysophospholipids and acylcarnitine species
Tobias Harm, Xiaoqing Fu, Moritz Frey, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2

Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via the Olfr2 signaling pathway in vitro and in vivo
Jinqian Mao, Yunfei Chen, Qiushuo Zong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

Hemin-induced platelet activation is regulated via ACKR3 chemokine surface receptor - implications for passivation of vulnerable atherosclerotic plaque
Zoi Laspa, Valerie Dicenta‐Baunach, David Schaale, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

Shexiang Baoxin Pill enriches Lactobacillus to regulate purine metabolism in patients with stable coronary artery disease
Gaosong Wu, Jingyu Liao, Xiaoyan Zhu, et al.
Phytomedicine (2024) Vol. 130, pp. 155727-155727
Closed Access | Times Cited: 2

Critical shifts in lipid metabolism promote megakaryocyte differentiation and proplatelet formation
Bianca de Jonckheere, Ferdinand Kollotzek, Patrick Münzer, et al.
Nature Cardiovascular Research (2023) Vol. 2, Iss. 9, pp. 835-852
Open Access | Times Cited: 6

Dual-targeting fucoidan-based microvesicle for arterial thrombolysis and re-occlusion inhibition
Zhechang Chen, Caijie Yuan, Yaxin Ye, et al.
Carbohydrate Polymers (2023) Vol. 328, pp. 121703-121703
Closed Access | Times Cited: 6

cGMP modulates hemin-mediated platelet death
Anne‐Katrin Rohlfing, Marcel Kremser, David Schaale, et al.
Thrombosis Research (2023) Vol. 234, pp. 63-74
Closed Access | Times Cited: 6

Effect of lipid-lowering therapy on platelet reactivity in patients treated with and without antiplatelet therapy
Salvatore Giordano, Francesco Franchi, Fabiana Rollini, et al.
Minerva Cardiology and Angiology (2023) Vol. 72, Iss. 5
Closed Access | Times Cited: 5

Page 1 - Next Page

Scroll to top